Results 111 to 120 of about 32,793 (264)

Safety and efficacy of eculizumab in adult and pediatric patients with aHUS, with or without baseline dialysis [PDF]

open access: yes, 2015
C
Hourmant, Maryvonne   +5 more
core   +1 more source

High coverage of diverse invasive meningococcal serogroup B strains by the 4-component vaccine 4CMenB in Australia, 2007–2011: Concordant predictions between MATS and genetic MATS [PDF]

open access: hybrid, 2021
Sarah Tozer   +13 more
openalex   +1 more source

Strategic evaluations and techno-economic networks. Vaccine innovation in the Cuban biotech sector: for public health – or for profits? [PDF]

open access: yes
In this paper the Cuban biotech sector with its highly integrated vaccine industry is analyzed in the perspective of the techno-economic network model of Michel Callon. The paper discusses the strategic evaluations that have been performed in the sector.
Jens Plahte
core  

The Update, February 13, 2012 [PDF]

open access: yes, 2012
The Update is a bi-weekly web newsletter published by the Iowa Department of Public Health's Bureau of Family Health. It is posted the second and fourth week of every month, and provides useful job resource information for departmental health care ...

core  

Genomic Characterization of Invasive Meningococcal Serogroup B Isolates and Estimation of 4CMenB Vaccine Coverage in Finland

open access: gold, 2020
Margherita Bodini   +11 more
openalex   +1 more source

Bioinformatics Analysis of Global Diversity in Meningococcal Vaccine Antigens over the Past 10 Years: Vaccine Efficacy Prognosis. [PDF]

open access: yesMed Sci (Basel), 2023
Savitskaya VY   +7 more
europepmc   +1 more source

What are the indications for meningococcal vaccination? [PDF]

open access: yes, 2007
Routine vaccination with the meningococcal conjugate vaccine MCV4 (Menactra) is indicated for all US adolescents entering high school and for college freshmen living in dormitories (strength of recommendation [SOR]: B, based on observational studies ...
Edgerton, Lisa   +2 more
core  

Home - About - Disclaimer - Privacy